ADMA Biologics, Inc. (ADMA)
USD 17.7
(-4.99%)
USD 17.7
(-4.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.8 Million | -59.5 Million | -112.36 Million | -102 Million | -76.19 Million | -62.67 Million |
| Net Income | -28.23 Million | -65.9 Million | -71.64 Million | -75.74 Million | -48.27 Million | -65.74 Million |
| Depreciation & Amortization | 8.33 Million | 7.11 Million | 5.49 Million | 3.94 Million | 3.25 Million | 3.44 Million |
| Deferred income taxes | 17.7 Million | - | 220.76 Thousand | -910.1 Thousand | -1.35 Million | 122.19 Thousand |
| Stock-based compensation | 6.18 Million | 5.21 Million | 3.48 Million | 2.85 Million | 2.65 Million | - |
| Change in working capital | -10.12 Million | -18.28 Million | -51.68 Million | -33.78 Million | -33.5 Million | -3.68 Million |
| Other non-cash items | 14.94 Million | 12.35 Million | 1.75 Million | 1.63 Million | 1.03 Million | 961.32 Thousand |
| Investing Cash Flow | -4.98 Million | -13.91 Million | -13.51 Million | -12.72 Million | -3.81 Million | -2.09 Million |
| Investments in PPE | -4.98 Million | -13.91 Million | -13.51 Million | -12.72 Million | -3.81 Million | -2.09 Million |
| Acquisitions | - | - | - | 2000.00 | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -210 Thousand | - | - | 2000.00 | - | - |
| Financing Cash Flow | -38.98 Million | 108.85 Million | 121.04 Million | 143.89 Million | 80 Million | 42.92 Million |
| Debt repayment | -38.67 Million | -100.03 Million | -34.29 Thousand | -13.98 Million | -30.02 Million | -36.27 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.41 Million | -2.89 Million | -61.59 Thousand | - | - | - |
| Common Stock Issuance | 1.1 Million | 64.64 Million | 121.14 Million | 131.19 Million | 48.39 Million | - |
| Other Financing Activities | -1.41 Million | 150.04 Million | 61.59 Thousand | 26.68 Million | 61.63 Million | 42.95 Million |
| Accounts receivables | -11.91 Million | 13.07 Million | -15.33 Million | -9.76 Million | -2.07 Million | 2.48 Million |
| Accounts payables | 3.83 Million | 799.98 Thousand | 1.35 Million | 1.89 Million | 3.27 Million | -20.48 Thousand |
| Inventory | -9.62 Million | -38.55 Million | -43.18 Million | -28.47 Million | -34.65 Million | -5.98 Million |
| Other working capital | 7.58 Million | 6.39 Million | 5.49 Million | 2.55 Million | -49.36 Thousand | -167.68 Thousand |
| Cash at beginning of period | 86.52 Million | 51.08 Million | 55.92 Million | 26.75 Million | 26.75 Million | 48.6 Million |
| Cash at end of period | 51.35 Million | 86.52 Million | 51.08 Million | 55.92 Million | 26.75 Million | 26.75 Million |
| Capital Expenditure | -4.98 Million | -13.91 Million | -13.51 Million | -12.72 Million | -3.81 Million | -2.09 Million |
| Effect of forex changes on cash | 458.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -35.16 Million | 35.43 Million | -4.83 Million | 29.16 Million | -2717.00 | -21.85 Million |
| Free Cash Flow | 3.81 Million | -73.41 Million | -125.88 Million | -114.72 Million | -80 Million | -64.77 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 32.06 Million | 17.8 Million | -28.23 Million | -17.64 Million | 2.56 Million | -6.37 Million |
| Depreciation & Amortization | 2.04 Million | 2.11 Million | 8.33 Million | 2.1 Million | 2.09 Million | 2.09 Million |
| Deferred income taxes | - | - | 17.7 Million | -6.86 Million | 92.85 Thousand | - |
| Stock-based compensation | 2.86 Million | 2.14 Million | 6.18 Million | 1.74 Million | 1.69 Million | 1.63 Million |
| Change in working capital | 8.48 Million | -24.51 Million | -10.12 Million | 3.6 Million | 3.86 Million | -5.05 Million |
| Other non-cash items | -8.42 Million | 33.18 Million | 14.94 Million | 34.64 Million | 1.67 Million | 1.63 Million |
| Investing Cash Flow | -2.36 Million | -2.36 Million | -4.98 Million | -1.4 Million | -756.55 Thousand | -872.63 Thousand |
| Investments in PPE | -2.36 Million | -2.36 Million | -4.98 Million | -1.4 Million | -756.55 Thousand | -872.63 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -299 Thousand | -15 Thousand | -210 Thousand | -210 Thousand | - | - |
| Financing Cash Flow | -362 Thousand | -1.44 Million | -38.98 Million | -38.99 Million | 415.35 Thousand | 240.11 Thousand |
| Debt repayment | - | - | -38.67 Million | -38.66 Million | - | -6465.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -693 Thousand | -2.47 Million | -1.41 Million | -340.45 Thousand | -208.63 Thousand | -224.96 Thousand |
| Common Stock Issuance | 331 Thousand | 1.02 Million | 1.1 Million | 8461.00 | 623.99 Thousand | 471.54 Thousand |
| Other Financing Activities | -693 Thousand | -2.47 Million | -1.41 Million | -340.45 Thousand | -208.63 Thousand | 246.58 Thousand |
| Accounts receivables | 19.5 Million | -22.2 Million | -11.91 Million | 3.89 Million | 5.41 Million | -10.21 Million |
| Accounts payables | -1.85 Million | 447 Thousand | 3.83 Million | 4.99 Million | -9907.00 | -871.95 Thousand |
| Inventory | -2.07 Million | -4.82 Million | -9.62 Million | -9.78 Million | -1.33 Million | 2.2 Million |
| Other working capital | -7.09 Million | 2.06 Million | 7.58 Million | 4.5 Million | -204.72 Thousand | 3.82 Million |
| Cash at beginning of period | 45.32 Million | 51.35 Million | 86.52 Million | 74.15 Million | 62.51 Million | 69.2 Million |
| Cash at end of period | 88.24 Million | 45.32 Million | 51.35 Million | 51.35 Million | 74.15 Million | 62.51 Million |
| Capital Expenditure | -2.36 Million | -2.36 Million | -4.98 Million | -1.4 Million | -756.55 Thousand | -872.63 Thousand |
| Effect of forex changes on cash | - | - | 458.00 | 458.00 | -6.98 Million | - |
| Net cash flow / Change in cash | 42.91 Million | -6.02 Million | -35.16 Million | -22.8 Million | 11.64 Million | -6.69 Million |
| Free Cash Flow | 43.28 Million | -4.58 Million | 3.81 Million | 16.18 Million | 11.22 Million | -6.93 Million |
GTBO
CYIENTDLM
LVH
9663
NVRO
NRL